Product Detail
Tipiracil-13C, 15N2
Tipiracil Stable Isotopes
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category
Stable Isotopes
API Family
Tipiracil
Storage
Refer MSDS for complete information.
Hazard Information
Refer MSDS for complete information.
Tipiracil-13C, 15N2 Product Information
Tipiracil-13C, 15N2 is listed under Stable Isotopes. It is associated with Tipiracil and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-103799.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Tipiracil-13C, 15N2
CAS No.
183204-74-2(unlabelled)
CAT No.
CS-T-103799
Molecular Formula
C₈¹³CH₁₁ClN₂¹⁵N₂O₂
Molecular Weight
245.64
Category
API Family
Storage Condition
Refer MSDS for complete information.
SMILES
N=C1CCCN1CC2=C(Cl)C([15NH][13C]([15NH]2)=O)=O
IUPAC Name
5-Chloro-6-[(2-imino-1-pyrrolidinyl)methyl]-2,4(1H,3H)-pyrimidinedione-13C, 15N2; MA 1-13C, 15N2; TPI-13C, 15N2
Hazard Compound
Refer MSDS for complete information.
Description
Overview
Tipiracil-13C, 15N2 is carbon-13 and nitrogen-15 labeled Tipiracil, an inhibitor of human thymidine phosphorylase (TP).Thymidine phosphorylase is an enzyme that converts thymidine to thymine and is a platelet-derived endothelial cell growth factor.
Synonyms
5-Chloro-6-[(2-imino-1-pyrrolidinyl)methyl]-2,4(1H,3H)-pyrimidinedione-13C, 15N2; MA 1-13C, 15N2; TPI-13C, 15N2
Application Notes
Tipiracil-13C, 15N2 is carbon-13 and nitrogen-15 labeled Tipiracil, an inhibitor of human thymidine phosphorylase (TP).Thymidine phosphorylase is an enzyme that converts thymidine to thymine and is a platelet-derived endothelial cell growth factor.
References
Grierson, J. R., et al.:Â Nucleosides Nucleotides Nucleic Acids 29, 49 (2010); Takao, S., et al.:Â Cancer Res. 60, 5345 (2000)
